- Report
- January 2026
- 194 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 187 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 190 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 196 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 197 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 184 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 186 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 185 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- November 2025
- 182 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- October 2025
- 199 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 189 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 198 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 182 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 182 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- August 2025
- 193 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- July 2025
- 150 Pages
Global
From €5204EUR$5,950USD£4,490GBP
- Report
- January 2026
- 198 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- February 2026
- 521 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 385 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 183 Pages
Global
From €5117EUR$5,850USD£4,415GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more